Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0MF9H
|
||||
| Former ID |
DIB006194
|
||||
| Drug Name |
Delucemine
|
||||
| Synonyms |
Delucemine hydrochloride; NPS-1506
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Depression [ICD9: 311; ICD10:F30-F39] | Discontinued in Phase 1 | [1] | ||
| Company |
NPS Pharmaceuticals Inc
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C16H17F2N
|
||||
| Canonical SMILES |
c1(C(c2cc(F)ccc2)CCNC)cc(F)ccc1
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | NMDA receptor | Target Info | Modulator | [2] | |
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800009310) | ||||
| REF 2 | NPS 1506, a novel NMDA receptor antagonist and neuroprotectant. Review of preclinical and clinical studies. Ann N Y Acad Sci. 1999;890:450-7. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.